Coronary Artery Disease Clinical Trial
— SPEQUAOfficial title:
Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT)
This pilot study wants to determine to which extent SPCCT allows obtaining images with improved quality and diagnostic confidence when compared to standard Dual Energy CT (DECT), both with and without contrast agent injection. Depending on the anatomical structures/organs to be visualized during CT examinations, different scanning protocols are performed with quite variable ionizing radiation doses. Therefore, in order to obtain the most extensive and representative results of the improvement in image quality between SPCCT and DECT that will be performed CT imaging on several body regions and structures, including diabetic foot, diabetic calcium coronary scoring, adrenal glands, coronary arteries, lung parenchyma, kidney stones, inner ear, brain and joints, earl/temporal bone, colorectal carcinosis.
Status | Recruiting |
Enrollment | 339 |
Est. completion date | January 29, 2026 |
Est. primary completion date | January 29, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients presenting following one of following medical conditions: 1. Asymptomatic type 1 or 2 diabetes as regard to cardiovascular risks 2. Diabetic foot ulcer 3. Adrenal glands lesions: Adrenal incidentaloma or hyperaldosteronism or macroadenoma 4. Urinary stone(s) 5. Known Coronary artery disease: Stent imaging or control of calcified plaques 6. Diffuse Interstitial Lung Diseases: Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis, Ground Glass Opacification, Chronic Thromboembolic Pulmonary Hypertension 7. Conductive hearing loss 8. Brain stroke (late or post thrombectomy) 9. Intracranial arteriovenous malformation treated with coils or Onyx 10. Joints diseases in haemophilia 11. Ear/temporal bone 12. Colorectal carcinosis 13. Dissection aortique de type A opérée ou de type B non opérée, hématome intramural - Patient has accepted to participate to the study and has signed the written consent; - Pre-menopausal women only: Negative urinary pregnancy test on the day of imaging before the administration of study drug; - Patient is affiliated to the French social security Exclusion Criteria: - Contraindication to the use of iodine containing contrast media (including subjects with suspicion for/or known to have NSF) (if injection); - History of severe allergic or anaphylactic reaction to any allergen including drugs and contrast agents (as judged by the investigator, taking into account the intensity of the event); - History of delayed major or delayed cutaneous reaction to Iomeron injection - Estimated Glomerular Filtration Rate (eGFR) value < 30 mL/min/1.73 m2 derived from a serum creatinine result within 1 month before the imaging for examinations with contrast agent. - Any subject on hemodialysis or peritoneal dialysis; - Suspected clinical instability or unpredictability of the clinical course during the study period (e.g. due to previous surgery); - Pregnant or nursing (including pumping for storage and feeding); - Patient under guardianship, curatorship or safeguard of justice. |
Country | Name | City | State |
---|---|---|---|
France | Hôpital Cardiologique Louis Pradel - Hospices Civils de Lyon | Bron | Avenue Doyen Lépine |
Lead Sponsor | Collaborator |
---|---|
Hospices Civils de Lyon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | quality of the images | A single four-point scale will be used (1: unacceptable, 2: usable under limited conditions, 3: probably acceptable, 4: fully acceptable) based on the European guidelines on quality criteria for computed tomography | Day 8 | |
Secondary | Diagnostic confidence graded | The diagnostic confidence grade will be calculated on a four-point scale (1: insufficient, 2: poor, 3: average, 4: good). | Day 8 | |
Secondary | Subjective image quality graded | It will be calculated on a five-point scale (1: poor, 2: fair, 3: average, 4: good, 5: excellent) for each following criterion: noise, artifacts and sharpness. | Day 8 | |
Secondary | CT Dose Index volumic (CTDIvol) | To determine the radiation dose delivered to the patients during the DECT and SPCCT imaging procedures.
The CTDI is an estimation of the dose delivered to the organs for each acquired section that is based on acquisition parameters of a water phantom with a 32 cm diameter. The value is expressed in milligray (mGy). |
Day 8 | |
Secondary | Dose Length Product (DLP) | To determine the radiation dose delivered to the patients during the DECT and SPCCT imaging procedures.
The DLP is obtained as follows: CTDI * length of body explored = value in mGy.cm. |
Day 8 | |
Secondary | Equivalent dose (mSv) | To determine the radiation dose delivered to the patients during the DECT and SPCCT imaging procedures.
The equivalent dose is obtained by multiplying the DLP to the specific organ conversion factor. |
Day 8 | |
Secondary | Quantitatively image quality : Noise | The noise by selecting regions of interest (ROI) will calculated. | Day 8 | |
Secondary | Quantitatively image quality : Density | The density (HU) by selecting regions of interest (ROI) will calculated. | Day 8 | |
Secondary | Quantitatively image quality : contrast-to-noise ratio | The contrast-to-noise ratio (CNR) by selecting regions of interest (ROI) will calculated. | Day 8 | |
Secondary | Depiction of anatomical structures of interest | Depiction of anatomical structures of interest will be graded on a four-point scale (1: visualization just possible, 2: unclear borders but different structures already visible, 3: very good visualization, well-defined anatomy, 4: perfect delineation of anatomy). | Day 8 | |
Secondary | Radiation dose | An average radiation dose delivered to the patients for each clinical application will be calculated. | Day 8 | |
Secondary | Statistical comparison between SPCCT and DECT | Statistical comparison between SPCCT and DECT will be performed over all images and anatomical structures globally and also for each clinical application of interest. | Day 8 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |